Literature DB >> 1703020

An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenase.

L J Windsor1, H Birkedal-Hansen, B Birkedal-Hansen, J A Engler.   

Abstract

The cDNA that encodes the proenzyme form of human fibroblast collagenase has been expressed in Escherichia coli. It has been shown by a number of criteria to be functionally identical with the enzyme isolated from human sources. Mutations of each of three cysteine residues found in procollagenase were constructed by site-directed mutagenesis of the cDNA. The relative activities of these mutants were compared to the wild-type enzyme. All of the mutants retained proteolytic activity, but not necessarily on collagen. Mutations that interfere with the formation of the sulfhydryl bridge in the carboxy-terminal domain in some cases increased and in other cases decreased the rate of casein cleavage. On the basis of extensive autolysis within E. coli of a mutant with a replacement of cysteine-73, the procollagenase molecule produced appeared to be either spontaneously active or perhaps more susceptible to autolytic activation, despite the continued presence of the propeptide. Experiments designed to capture the active forms of the mutant by use of the irreversible inhibitor alpha 2-macroglobulin showed that some degree of latency still persisted in the autolytic mutant. These findings suggest that the cysteine at position 73 is important for maintaining the proenzyme in an inactive state but that the maintenance of latency in MMPs may be a complex process, involving a number of interactions between the propeptide domain and the remainder of the collagenase molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703020     DOI: 10.1021/bi00217a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Analysis of matrix metalloproteinase-1 gene polymorphisms and expression in benign and malignant breast tumors.

Authors:  Jing Zhou; Constance Brinckerhoff; Susan Lubert; Kui Yang; Jasmine Saini; Jeffrey Hooke; Richard Mural; Craig Shriver; Stella Somiari
Journal:  Cancer Invest       Date:  2011-11       Impact factor: 2.176

2.  Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity.

Authors:  T Hirose; C Patterson; T Pourmotabbed; C L Mainardi; K A Hasty
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

3.  Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin.

Authors:  Q A Sang; M K Bodden; L J Windsor
Journal:  J Protein Chem       Date:  1996-04

4.  Fragmentation of human polymorphonuclear-leucocyte collagenase.

Authors:  V Knäuper; A Osthues; Y A DeClerck; K E Langley; J Bläser; H Tschesche
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

5.  Binding of gelatinases A and B to type-I collagen and other matrix components.

Authors:  J A Allan; A J Docherty; P J Barker; N S Huskisson; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

Review 6.  Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.

Authors:  Christopher M Overall
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

7.  Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II.

Authors:  K Suzuki; M Lees; G F Newlands; H Nagase; D E Woolley
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

8.  Cloning of a 72 kDa matrix metalloproteinase (gelatinase) from chicken embryo fibroblasts using gene family PCR: expression of the gelatinase increases upon malignant transformation.

Authors:  R T Aimes; D L French; J P Quigley
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

Review 9.  Matrix-degrading metalloproteinases in photoaging.

Authors:  Taihao Quan; Zhaoping Qin; Wei Xia; Yuan Shao; John J Voorhees; Gary J Fisher
Journal:  J Investig Dermatol Symp Proc       Date:  2009-08

10.  Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study.

Authors:  S M Shalaby; M Bosseila; M M Fawzy; D M Abdel Halim; S S Sayed; R S H M Allam
Journal:  Lasers Med Sci       Date:  2016-08-10       Impact factor: 3.161

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.